Insider sale: 4,333 shares reported in Form 144

Sandra Calvin filed a Form 144 reporting proposed resales of Common Stock and recent dispositions.

Rhea-AI Filing Summary

Sandra Calvin filed a Form 144 reporting proposed resales of Common Stock and recent dispositions. The filing lists 1,263 restricted shares dated 01/21/2025, 5,464 restricted shares dated 01/31/2025, and 15,250 shares from a stock option exercise dated 04/14/2026. It also reports 4,333 shares sold on 02/03/2026 for $139,177.16. A broker-dealer listed is Morgan Stanley Smith Barney LLC.

Insights

Securities Compliance Analyst

Form 144 lists proposed resale quantities and a recent sale; treatment is routine disclosure by an affiliate.

The filing enumerates specific lots: restricted stock grants on 01/21/2025 and 01/31/2025, and shares from a stock option exercise dated 04/14/2026. It also records a prior sale of $139,177.16 on 02/03/2026.

Regulatory focus: ensure sales comply with Rule 144 timing and volume conditions. Subsequent SEC filings or broker confirmations would show actual resale dates and settlement details.

Key Figures

Shares sold in past 3 months: 4,333 shares Proceeds reported: $139,177.16 Restricted shares (lot 1): 1,263 shares +2 more

5 metrics

Shares sold in past 3 months 4,333 shares sale dated 02/03/2026

Proceeds reported $139,177.16 sale of 4,333 shares on 02/03/2026

Restricted shares (lot 1) 1,263 shares restricted stock dated 01/21/2025

Restricted shares (lot 2) 5,464 shares restricted stock dated 01/31/2025

Shares from option exercise 15,250 shares stock option exercise dated 04/14/2026

Key Terms

Form 144, Restricted Stock, Stock Option Exercise, Issuer

4 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock financial

"Common | 01/21/2025 | Restricted Stock"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Stock Option Exercise financial

"Common | 04/14/2026 | Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Issuer regulatory

"Restricted Stock | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Sandra Calvin report on the Form 144 for TVTX?

The Form 144 lists proposed resales of Common Stock including 1,263, 5,464, and 15,250 share lots. It also reports a prior sale of 4,333 shares on 02/03/2026 for $139,177.16.

How many shares did Sandra Calvin sell in the past three months (TVTX)?

She sold 4,333 shares on 02/03/2026. The filing records the transaction value as $139,177.16, which is the reported proceeds from that sale.

What types of securities are listed on the Form 144 for TVTX?

The filing lists Restricted Stock grants and shares from a Stock Option Exercise, each tied to specific dates: 01/21/2025, 01/31/2025, and 04/14/2026.

Which broker-dealer is named on the Form 144 for TVTX?

The broker-dealer listed is Morgan Stanley Smith Barney LLC at 1 New York Plaza, 8th Floor, New York, NY. That entity is shown in the filer information section.

Does the Form 144 show the timing for future resales of TVTX shares?

The filing lists the lots proposed for resale with their grant/exercise dates but does not state specific future resale execution dates. It lists the quantities and the related grant/exercise dates only.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/14/2026 - 04:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001882909
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TRAVERE THERAPEUTICS, INC.
SEC File Number	001-36257
Address of Issuer	3611 Valley Centre Drive Suite 300 San Diego CALIFORNIA 92130
Phone	888-969-7879
Name of Person for Whose Account the Securities are To Be Sold	SANDRA CALVIN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	21977	902595.39	92241550	04/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/21/2025	Restricted Stock	Issuer			1263	01/21/2025	Not Applicable
Common	01/31/2025	Restricted Stock	Issuer			5464	01/31/2025	Not Applicable
Common	04/14/2026	Stock Option Exercise	Issuer			15250	04/14/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SANDRA CALVIN 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	02/03/2026	4333	139177.16

144: Remarks and Signature

Remarks
Date of Notice	04/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Sandra Louise Calvin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)